Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Revenue 2020–2025
Adma Biologics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Adma Biologics Inc. revenue for the quarter ending March 31, 2026 was 114.5 M, a 0.27% decrease year-over-year.
- Adma Biologics Inc. revenue for the twelve months ending March 31, 2026 was 509.9 M.
- Adma Biologics Inc. annual revenue for 2025 was 510.2 M, a 19.63% increase from 2024.
- Adma Biologics Inc. annual revenue for 2024 was 426.5 M, a 65.15% increase from 2023.
- Adma Biologics Inc. annual revenue for 2023 was 258.2 M, a 67.59% increase from 2022.
- Adma Biologics Inc. annual revenue for 2022 was 154.1 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adma Biologics Inc. Revenue — FAQ
Adma Biologics Inc. (ADMA) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Adma Biologics Inc.'s revenue?
Adma Biologics Inc. (ADMA) reported revenue of $510M for fiscal 2025.
Where can I see ADMA's revenue history?
The chart and table above show Adma Biologics Inc.'s revenue by year and by quarter, including the growth rate.